APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hemoperfusion

Hemoperfusion is a treatment technique in which large volumes of the patient's blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Hemoperfusion is a treatment technique in which large volumes of the patient's blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents.

Selected research

Market Structure

Global Hemoperfusion Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025189 pages

Choose your research edition.

Industry ResearchHemoperfusion Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Hemoperfusion Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Hemoperfusion Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hemoperfusion Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Hemoperfusion Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Hemoperfusion is a treatment technique in which large volumes of the patient's blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents.

China is the largest Hemoperfusion market with about 65% market share. Europe is follower, accounting for about 19% market share.The key manufacturers are Jafron Biomedical, Baxter (Gambro), Asahi-Kasei, Biosun Medical, Kaneka, Toray Medical, Cytosorbents, Aier, Zibo Kangbei etc. Top 3 companies occupied about 81% market share.

This report provides an overview of the global Hemoperfusion market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Hemoperfusion and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Hemoperfusion sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Hemoperfusion market size, projected growth trends, production technologies, key applications, and end-use industries.

Hemoperfusion Segment by Company

Jafron Biomedical

Baxter (Gambro)

Asahi-Kasei

Biosun Medical

Kaneka

Toray Medical

Cytosorbents

Aier

Zibo Kangbei

Hemoperfusion Segment by Type

Activated Carbon Adsorption

Resin Adsorption

Hemoperfusion Segment by Application

Hepatic Encephalopathy

Certain Autoimmune Diseases

Drug Overdose

Specific Intoxications

Others

Hemoperfusion Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hemoperfusion market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hemoperfusion and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hemoperfusion.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Hemoperfusion market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Hemoperfusion manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Hemoperfusion in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Hemoperfusion in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Hemoperfusion Industry Trends Table 2. Hemoperfusion Industry Drivers Table 3. Hemoperfusion Industry Opportunities and Challenges Table 4. Hemoperfusion Industry Restraints Table 5. Global Hemoperfusion Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Hemoperfusion Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Hemoperfusion Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Hemoperfusion Sales Market Share by Manufacturers Table 9. Global Hemoperfusion Average Sales Price (USD/Unit) of Manufacturers (2021-2026) Table 10. Global Hemoperfusion Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Hemoperfusion Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Hemoperfusion Manufacturers, Product Type & Application Table 13. Global Hemoperfusion Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Hemoperfusion by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Activated Carbon Adsorption Table 17. Major Manufacturers of Resin Adsorption Table 18. Global Hemoperfusion Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Hemoperfusion Sales by Type (2021-2026) & (K Units) Table 20. Global Hemoperfusion Sales by Type (2027-2032) & (K Units) Table 21. Global Hemoperfusion Sales Market Share by Type (2021-2026) Table 22. Global Hemoperfusion Sales Market Share by Type (2027-2032) Table 23. Global Hemoperfusion Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Hemoperfusion Revenue by Type (2021-2026) & (K Units) Table 25. Global Hemoperfusion Revenue by Type (2027-2032) & (K Units) Table 26. Global Hemoperfusion Revenue Market Share by Type (2021-2026) Table 27. Global Hemoperfusion Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hepatic Encephalopathy Table 29. Major Manufacturers of Certain Autoimmune Diseases Table 30. Major Manufacturers of Drug Overdose Table 31. Major Manufacturers of Specific Intoxications Table 32. Major Manufacturers of Others Table 33. Global Hemoperfusion Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Hemoperfusion Sales by Application (2021-2026) & (K Units) Table 35. Global Hemoperfusion Sales by Application (2027-2032) & (K Units) Table 36. Global Hemoperfusion Sales Market Share by Application (2021-2026) Table 37. Global Hemoperfusion Sales Market Share by Application (2027-2032) Table 38. Global Hemoperfusion Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Hemoperfusion Revenue by Application (2021-2026) & (K Units) Table 40. Global Hemoperfusion Revenue by Application (2027-2032) & (K Units) Table 41. Global Hemoperfusion Revenue Market Share by Application (2021-2026) Table 42. Global Hemoperfusion Revenue Market Share by Application (2027-2032) Table 43. Global Hemoperfusion Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Hemoperfusion Sales by Region (2021-2026) & (K Units) Table 45. Global Hemoperfusion Sales Market Share by Region (2021-2026) Table 46. Global Hemoperfusion Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global Hemoperfusion Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Hemoperfusion Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America Hemoperfusion Sales by Country (2021-2026) & (K Units) Table 50. North America Hemoperfusion Sales by Country (2027-2032) & (K Units) Table 51. Europe Hemoperfusion Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe Hemoperfusion Sales by Country (2021-2026) & (K Units) Table 53. Europe Hemoperfusion Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific Hemoperfusion Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific Hemoperfusion Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific Hemoperfusion Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa Hemoperfusion Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa Hemoperfusion Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa Hemoperfusion Sales by Country (2027-2032) & (K Units) Table 60. Global Hemoperfusion Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Hemoperfusion Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Hemoperfusion Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Hemoperfusion Revenue Market Share by Region (2021-2026) Table 64. Global Hemoperfusion Revenue Market Share by Region (2027-2032) Table 65. Jafron Biomedical Company Information Table 66. Jafron Biomedical Business Overview Table 67. Jafron Biomedical Hemoperfusion Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Jafron Biomedical Hemoperfusion Product Portfolio Table 69. Jafron Biomedical Recent Development Table 70. Baxter (Gambro) Company Information Table 71. Baxter (Gambro) Business Overview Table 72. Baxter (Gambro) Hemoperfusion Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Baxter (Gambro) Hemoperfusion Product Portfolio Table 74. Baxter (Gambro) Recent Development Table 75. Asahi-Kasei Company Information Table 76. Asahi-Kasei Business Overview Table 77. Asahi-Kasei Hemoperfusion Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Asahi-Kasei Hemoperfusion Product Portfolio Table 79. Asahi-Kasei Recent Development Table 80. Biosun Medical Company Information Table 81. Biosun Medical Business Overview Table 82. Biosun Medical Hemoperfusion Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Biosun Medical Hemoperfusion Product Portfolio Table 84. Biosun Medical Recent Development Table 85. Kaneka Company Information Table 86. Kaneka Business Overview Table 87. Kaneka Hemoperfusion Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Kaneka Hemoperfusion Product Portfolio Table 89. Kaneka Recent Development Table 90. Toray Medical Company Information Table 91. Toray Medical Business Overview Table 92. Toray Medical Hemoperfusion Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Toray Medical Hemoperfusion Product Portfolio Table 94. Toray Medical Recent Development Table 95. Cytosorbents Company Information Table 96. Cytosorbents Business Overview Table 97. Cytosorbents Hemoperfusion Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Cytosorbents Hemoperfusion Product Portfolio Table 99. Cytosorbents Recent Development Table 100. Aier Company Information Table 101. Aier Business Overview Table 102. Aier Hemoperfusion Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Aier Hemoperfusion Product Portfolio Table 104. Aier Recent Development Table 105. Zibo Kangbei Company Information Table 106. Zibo Kangbei Business Overview Table 107. Zibo Kangbei Hemoperfusion Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Zibo Kangbei Hemoperfusion Product Portfolio Table 109. Zibo Kangbei Recent Development Table 110. Key Raw Materials Table 111. Raw Materials Key Suppliers Table 112. Hemoperfusion Distributors List Table 113. Hemoperfusion Customers List Table 114. Research Programs/Design for This Report Table 115. Authors List of This Report Table 116. Secondary Sources Table 117. Primary Sources List of Figures Figure 1. Hemoperfusion Product Image Figure 2. Global Hemoperfusion Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hemoperfusion Market Size (2021-2032) & (US$ Million) Figure 4. Global Hemoperfusion Sales (2021-2032) & (K Units) Figure 5. Global Hemoperfusion Average Price (USD/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Hemoperfusion Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Activated Carbon Adsorption Image Figure 9. Resin Adsorption Image Figure 10. Global Hemoperfusion Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Hemoperfusion Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Hemoperfusion Sales Market Share by Type (2021-2032) Figure 13. Global Hemoperfusion Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Hemoperfusion Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Hemoperfusion Revenue Market Share by Type (2021-2032) Figure 16. Hepatic Encephalopathy Image Figure 17. Certain Autoimmune Diseases Image Figure 18. Drug Overdose Image Figure 19. Specific Intoxications Image Figure 20. Others Image Figure 21. Global Hemoperfusion Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Hemoperfusion Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Hemoperfusion Sales Market Share by Application (2021-2032) Figure 24. Global Hemoperfusion Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Hemoperfusion Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Hemoperfusion Revenue Market Share by Application (2021-2032) Figure 27. North America Hemoperfusion Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America Hemoperfusion Sales Market Share by Country (2021-2032) Figure 29. U.S. Hemoperfusion Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada Hemoperfusion Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico Hemoperfusion Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Hemoperfusion Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Hemoperfusion Sales Market Share by Country (2021-2032) Figure 34. Germany Hemoperfusion Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France Hemoperfusion Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. Hemoperfusion Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy Hemoperfusion Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands Hemoperfusion Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Hemoperfusion Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Hemoperfusion Sales Market Share by Country (2021-2032) Figure 41. China Hemoperfusion Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan Hemoperfusion Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea Hemoperfusion Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia Hemoperfusion Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India Hemoperfusion Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia Hemoperfusion Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Hemoperfusion Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Hemoperfusion Sales Market Share by Country (2021-2032) Figure 49. Brazil Hemoperfusion Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa Hemoperfusion Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia Hemoperfusion Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey Hemoperfusion Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina Hemoperfusion Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE Hemoperfusion Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt Hemoperfusion Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile Hemoperfusion Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global Hemoperfusion Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Hemoperfusion Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Hemoperfusion Revenue (2021-2032) & (US$ Million) Figure 60. North America Hemoperfusion Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Hemoperfusion Revenue (2021-2032) & (US$ Million) Figure 62. Europe Hemoperfusion Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Hemoperfusion Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Hemoperfusion Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Hemoperfusion Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Hemoperfusion Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Hemoperfusion Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Hemoperfusion Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Activated Carbon Adsorption
  • Resin Adsorption
Applications
  • Hepatic Encephalopathy
  • Certain Autoimmune Diseases
  • Drug Overdose
  • Specific Intoxications
  • Others
Companies covered
  • Jafron Biomedical
  • Baxter (Gambro)
  • Asahi-Kasei
  • Biosun Medical
  • Kaneka
  • Toray Medical
  • Cytosorbents
  • Aier
  • Zibo Kangbei

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Hemoperfusion Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Hemoperfusion Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Hemoperfusion Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Hemoperfusion Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Hemoperfusion Market Dynamics
  1. 2.1 Hemoperfusion Industry Trends
  2. 2.2 Hemoperfusion Industry Drivers
  3. 2.3 Hemoperfusion Industry Opportunities and Challenges
  4. 2.4 Hemoperfusion Industry Restraints
3 Hemoperfusion Market by Manufacturers
  1. 3.1 Global Hemoperfusion Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Hemoperfusion Sales by Manufacturers (2021-2026)
  3. 3.3 Global Hemoperfusion Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Hemoperfusion Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Hemoperfusion Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Hemoperfusion Manufacturers, Product Type & Application
  7. 3.7 Global Hemoperfusion Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Hemoperfusion Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Hemoperfusion Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Hemoperfusion Tier 1, Tier 2, and Tier 3
4 Hemoperfusion Market by Type
  1. 4.1 Hemoperfusion Type Introduction
  2. 4.1.1 Activated Carbon Adsorption
  3. 4.1.2 Resin Adsorption
  4. 4.2 Global Hemoperfusion Sales by Type
  5. 4.2.1 Global Hemoperfusion Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Hemoperfusion Sales by Type (2021-2032)
  7. 4.2.3 Global Hemoperfusion Sales Market Share by Type (2021-2032)
  8. 4.3 Global Hemoperfusion Revenue by Type
  9. 4.3.1 Global Hemoperfusion Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Hemoperfusion Revenue by Type (2021-2032)
  11. 4.3.3 Global Hemoperfusion Revenue Market Share by Type (2021-2032)
5 Hemoperfusion Market by Application
  1. 5.1 Hemoperfusion Application Introduction
  2. 5.1.1 Hepatic Encephalopathy
  3. 5.1.2 Certain Autoimmune Diseases
  4. 5.1.3 Drug Overdose
  5. 5.1.4 Specific Intoxications
  6. 5.1.5 Others
  7. 5.2 Global Hemoperfusion Sales by Application
  8. 5.2.1 Global Hemoperfusion Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Hemoperfusion Sales by Application (2021-2032)
  10. 5.2.3 Global Hemoperfusion Sales Market Share by Application (2021-2032)
  11. 5.3 Global Hemoperfusion Revenue by Application
  12. 5.3.1 Global Hemoperfusion Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Hemoperfusion Revenue by Application (2021-2032)
  14. 5.3.3 Global Hemoperfusion Revenue Market Share by Application (2021-2032)
6 Global Hemoperfusion Sales by Region
  1. 6.1 Global Hemoperfusion Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Hemoperfusion Sales by Region (2021-2032)
  3. 6.2.1 Global Hemoperfusion Sales by Region (2021-2026)
  4. 6.2.2 Global Hemoperfusion Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Hemoperfusion Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Hemoperfusion Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Hemoperfusion Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Hemoperfusion Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Hemoperfusion Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Hemoperfusion Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Hemoperfusion Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Hemoperfusion Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Hemoperfusion Revenue by Region
  1. 7.1 Global Hemoperfusion Revenue by Region
  2. 7.1.1 Global Hemoperfusion Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Hemoperfusion Revenue by Region (2021-2026)
  4. 7.1.3 Global Hemoperfusion Revenue by Region (2027-2032)
  5. 7.1.4 Global Hemoperfusion Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Hemoperfusion Revenue (2021-2032)
  8. 7.2.2 North America Hemoperfusion Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Hemoperfusion Revenue (2021-2032)
  11. 7.3.2 Europe Hemoperfusion Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Hemoperfusion Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Hemoperfusion Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Hemoperfusion Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Hemoperfusion Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Jafron Biomedical
  2. 8.1.1 Jafron Biomedical Company Information
  3. 8.1.2 Jafron Biomedical Business Overview
  4. 8.1.3 Jafron Biomedical Hemoperfusion Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Jafron Biomedical Hemoperfusion Product Portfolio
  6. 8.1.5 Jafron Biomedical Recent Developments
  7. 8.2 Baxter (Gambro)
  8. 8.2.1 Baxter (Gambro) Company Information
  9. 8.2.2 Baxter (Gambro) Business Overview
  10. 8.2.3 Baxter (Gambro) Hemoperfusion Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Baxter (Gambro) Hemoperfusion Product Portfolio
  12. 8.2.5 Baxter (Gambro) Recent Developments
  13. 8.3 Asahi-Kasei
  14. 8.3.1 Asahi-Kasei Company Information
  15. 8.3.2 Asahi-Kasei Business Overview
  16. 8.3.3 Asahi-Kasei Hemoperfusion Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Asahi-Kasei Hemoperfusion Product Portfolio
  18. 8.3.5 Asahi-Kasei Recent Developments
  19. 8.4 Biosun Medical
  20. 8.4.1 Biosun Medical Company Information
  21. 8.4.2 Biosun Medical Business Overview
  22. 8.4.3 Biosun Medical Hemoperfusion Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Biosun Medical Hemoperfusion Product Portfolio
  24. 8.4.5 Biosun Medical Recent Developments
  25. 8.5 Kaneka
  26. 8.5.1 Kaneka Company Information
  27. 8.5.2 Kaneka Business Overview
  28. 8.5.3 Kaneka Hemoperfusion Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Kaneka Hemoperfusion Product Portfolio
  30. 8.5.5 Kaneka Recent Developments
  31. 8.6 Toray Medical
  32. 8.6.1 Toray Medical Company Information
  33. 8.6.2 Toray Medical Business Overview
  34. 8.6.3 Toray Medical Hemoperfusion Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Toray Medical Hemoperfusion Product Portfolio
  36. 8.6.5 Toray Medical Recent Developments
  37. 8.7 Cytosorbents
  38. 8.7.1 Cytosorbents Company Information
  39. 8.7.2 Cytosorbents Business Overview
  40. 8.7.3 Cytosorbents Hemoperfusion Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Cytosorbents Hemoperfusion Product Portfolio
  42. 8.7.5 Cytosorbents Recent Developments
  43. 8.8 Aier
  44. 8.8.1 Aier Company Information
  45. 8.8.2 Aier Business Overview
  46. 8.8.3 Aier Hemoperfusion Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Aier Hemoperfusion Product Portfolio
  48. 8.8.5 Aier Recent Developments
  49. 8.9 Zibo Kangbei
  50. 8.9.1 Zibo Kangbei Company Information
  51. 8.9.2 Zibo Kangbei Business Overview
  52. 8.9.3 Zibo Kangbei Hemoperfusion Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Zibo Kangbei Hemoperfusion Product Portfolio
  54. 8.9.5 Zibo Kangbei Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Hemoperfusion Value Chain Analysis
  2. 9.1.1 Hemoperfusion Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Hemoperfusion Production Mode & Process
  6. 9.2 Hemoperfusion Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Hemoperfusion Distributors
  9. 9.2.3 Hemoperfusion Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst